Nan Fung Life Sciences
Eric joined NFLS/Pivotal in 2018, he was appointed as Finance Director, responsible for overall financial management of NFLS/Pivotal US & China operating and Pivotal China’s portfolio financial management. He has over 20 years of broad experiences in Greater China healthcare and life-sciences industry across various areas, including Corporate Finance, Financial Management, internal control development, commercial operations, Strategic business development, Distribution Channel management, Joint Venture and Post Merger Integration, etc. Prior to joining NFLS/Pivotal, Eric was a member of leadership team in several top healthcare/life sciences MNCs including Medtronic, Smith & Nephew and ConvaTec Group. Eric graduated from Shanghai Li Xin Accounting College, PRC, and he obtained MBA from Webster University, USA.
This person is not in any offices
Nan Fung Life Sciences
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations, and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices, and diagnostics) and across different development stages, Nan Fung Life Sciences has a significant presence in both US and Greater China.